Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.
Yoshimura A, Kato T, Nakai Y, Tsujihata M, Toyoda S, Sato M, Matsuzaki K, Nakata W, Takao T, Inoguchi S, Okuda Y, Yamamichi G, Ishizuya Y, Yamamoto Y, Hatano K, Kawashima A, Takada S, Inoue H, Nishimura K, Miyake O, Fujita K, Nakayama M, Nishimura K, Nonomura N.
Yoshimura A, et al. Among authors: takao t.
Int J Clin Oncol. 2024 Dec;29(12):1916-1924. doi: 10.1007/s10147-024-02612-1. Epub 2024 Sep 2.
Int J Clin Oncol. 2024.
PMID: 39222148
Free PMC article.